MAIA today
$1.01-$0.02 (-1.94%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourDescending Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $3.19
Key levels
Resistance$1.15
Resistance$1.06
Support$0.99
Support$0.87
Latest news & SEC filings
EarningsMAIA Biotechnology Posts Q3 2026 Financials
ProductMAIA Biotechnology wraps enrollment in third cohort of mid-stage ateganosine lung cancer trial
All MAIA news →About MAIA Biotechnology
MAIA Biotechnology develops experimental cancer therapies that aim at telomeres and the immune system. Its main drug candidate, ateganosine, is being tested in lung cancer and other solid tumors, frequently alongside checkpoint inhibitor medicines. The company runs its operations from the United States and also has activities in Australia and Romania.
Based on the company's 10-K filed Mar 23, 2026.
NYSE · Healthcare
MAIA Biotechnology, Inc. (MAIA)
What Is the Price Target for MAIA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is MAIA a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MAIA.
Start Free Trial →Is MAIA Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.88
0
Moat Score
NONE
1/9
Piotroski Score
-20.8
Altman Z-Score
What Is Smart Money Doing with MAIA?
Insider Signal
BUYING
7 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Guerrero Ramiro | director | Buy | 46,620 | $63K | Aug 28, 2026 |
| Guerrero Ramiro | director | Buy | 78,239 | $109K | Aug 27, 2026 |
| Guerrero Ramiro | director | Buy | 8,931 | $12K | Aug 26, 2026 |
| Vitoc Vlad | director officer 10% owner | Buy | 72,700 | $101K | Jun 1, 2026 |
| Smith Stan | director | Buy | 75,000 | $100K | Jun 1, 2026 |
| Gryaznov Sergei | officer | Buy | 2,000 | $3K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MAIA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
33.33%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for MAIA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MAIA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:57:01 | $1.01 | 1,300 | $$1K | SELL |
| 20:56:32 | $1.02 | 1,000 | $$1K | BUY |
| 20:56:14 | $1.01 | 1,300 | $$1K | SELL |
| 20:55:26 | $1.01 | 1,300 | $$1K | SELL |
| 20:54:39 | $1.01 | 1,300 | $$1K | SELL |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MAIA Biotechnology, Inc. (MAIA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MAIA — frequently asked questions
What is MAIA stock price today?
MAIA Biotechnology, Inc. (MAIA) is at $1.01, down 1.94% (-$0.02) at the Nov 12, 2026 close.
Why is MAIA stock moving today?
Latest MAIA news — Nov 10, 2026: MAIA Biotechnology Posts Q3 2026 Financials · Oct 7, 2026: MAIA Biotechnology wraps enrollment in third cohort of mid-stage ateganosine lung cancer trial
Did MAIA beat earnings?
MAIA last reported on Aug 10, 2026: EPS -$0.13 vs -$0.11 expected — a miss of 18.2%.
Does MAIA pay a dividend?
MAIA does not currently pay a dividend.
What are MAIA support and resistance levels?
Support: $0.99, $0.87. Resistance: $1.06, $1.15, $1.22.
What are insiders doing with MAIA?
Insider activity: BUYING, 7 buys and 0 sells in the last 90 days.
What is the latest news on MAIA?
Nov 10, 2026: MAIA Biotechnology Posts Q3 2026 Financials · Oct 7, 2026: MAIA Biotechnology wraps enrollment in third cohort of mid-stage ateganosine lung cancer trial